Displaying 281 - 300 of 604
National Association of Animal Breeders, Inc., In the Matter of
The National Association of Animal Breeders (NAAB) agreed to remove provisions in its Code of Ethics that the FTC charged limit competition among its members. The consent order settling the FTC’s allegations requires NAAB to end certain advertising restrictions, remove references to the restrictions from its website and official documents, publish and distribute an announcement regarding the consent agreement and the resulting changes to the Code of Ethics, and implement an antitrust compliance program.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
141 0215
Concordia Healthcare / Par Pharmaceutical, In the Matter of
Pharmaceutical companies Concordia Pharmaceuticals Inc. and Par Pharmaceutical, Inc. settled FTC charges that they entered into an unlawful agreement not to compete in the sale of generic versions of Kapvay, a prescription drug used to treat Attention Deficit Hyperactivity Disorder. As part of the settlement, the companies agreed not to enforce the anticompetitive provisions of their agreement. Until May 15, 2015, Concordia and Par were the only two firms permitted by the FDA to market generic Kapvay. Rather than competing against one another, Concordia agreed not to sell an authorized generic version of Kapvay in exchange for a share of Par’s revenues. Under the terms of the settlements, Concordia is prohibited from enforcing the anticompetitive provisions of its agreement with Par, including the profit-sharing provisions, and Par is prohibited from enforcing provisions that bar Concordia from agreeing not to sell an authorized generic version of Kapvay. Concordia began selling generic Kapvay after learning of the FTC’s investigation.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
151 0030
Public Statement
Room to Run: Regulatory Responses to Dynamic Changes in the Organization of Work
Date
File
Text of the Speech
(31.02 KB)
Separate Statement of Commissioners Maureen K. Ohlhausen and Joshua D. Wright Federal Trade Commission v. Cephalon, Inc.
Date
By
Maureen K. Ohlhausen, Former Commissioner;
Joshua D. Wright, Former Commissioner
Statement of the Federal Trade Commission FTC v. Cephalon, Inc.
Date
By
Edith Ramirez, Former Chairwoman;
Julie Brill, Former Commissioner;
Terrell McSweeny, Former Commissioner
FTC Chairwoman Ramirez Testifies Before House Judiciary Subcommittee On Antitrust Enforcement and Priorities to Promote Competition and Protect Consumers
Date
In testimony presented to a U.S. House of Representatives Judiciary subcommittee the Federal Trade Commission described its ongoing efforts to promote competition that benefits consumers and...
Prepared Statement of the Federal Trade Commission On “Oversight of the Enforcement of the Antitrust Laws”
Date
By
Edith Ramirez, Former Chairwoman
Matter Number
P859910
File
Text of the Commission Testimony
(96.98 KB)
Comment of the United States Federal Trade Commission and the United States Department of Justice Before the United States Department of Commerce Patent and Trademark Office: In the Matter of Request For Comments On Enhancing Patent Quality
Date
Matter Number
V150006
Docket Number
PTO-P-2014-0043
The FTC and the Department of Justice jointly submitted comments to the United States Patent and Trademark Office (PTO) in response to the PTO’s comprehensive initiative to increase the quality of...
Federal Trade Commission and Department of Justice Support U.S. Patent and Trademark Office Efforts to Increase the Quality of Granted Patents
Date
The Federal Trade Commission (FTC) and the Department of Justice (DOJ) submitted comments to the United States Patent and Trademark Office (PTO) in response to the PTO’s comprehensive initiative to...
Displaying 281 - 300 of 604